Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. BRT
BRT logo

BRT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
14.420
Open
14.370
VWAP
14.30
Vol
46.27K
Mkt Cap
274.84M
Low
14.180
Amount
661.73K
EV/EBITDA(TTM)
70.64
Total Shares
19.02M
EV
752.13M
EV/OCF(TTM)
25.77
P/S(TTM)
2.68
BRT Apartments Corp. is a real estate investment trust that owns, operates, and to a lesser extent, holds interest in joint ventures that own and operate multifamily properties. The Company owns or has interests in over 31 multifamily properties with 8,311units in 11 states and has preferred equity investments in two multi-family properties. Generally, its multifamily properties are garden apartments and, to a lesser extent, mid-rise or town home style properties that provide residents with amenities, such as a clubhouse, swimming pool, laundry facilities and Internet access. In addition to its multifamily properties and preferred loan investments, the Company owns assets, and in particular, real estate assets. Its properties include Silvana Oaks Apartments, Avondale Station, Brixworth at Bridge Street, Newbridge Commons, Crossings of Bellevue, Avalon Apartments, Parkway Grande, Woodland Trails, Grove at River Place, Kilburn Crossing, The Woodland Apartments, and others.
Show More

Events Timeline

(ET)
2026-03-11
16:40:00
New
BRT Apartments Declares Quarterly Dividend of 25 Cents
select
2025-09-11 (ET)
2025-09-11
16:21:19
BRT Apartments CFO George Zweier to Step Down, Isaac Kalish to Take Over
select
2025-07-21 (ET)
2025-07-21
16:18:32
BRT Apartments acquires apartment complex in Auburn for $36.5M
select
2025-03-12 (ET)
2025-03-12
16:54:40
BRT Apartments reports Q4 AFFO 37c, consensus 36c
select
2025-03-11 (ET)
2025-03-11
16:32:36
BRT Apartments increases share repurchase program to $10M
select

News

PRnewswire
8.5
01-16PRnewswire
Bioretec Secures CMS TPT Status for RemeOs™ Trauma Screw, Setting New Orthopedic Standard
  • Innovative Payment Mechanism: Bioretec's RemeOs™ Trauma Screw received Transitional Pass-Through Payment (TPT) status from CMS effective October 1, 2025, aimed at reducing the cost burden on hospitals and surgical centers for adopting new technologies, thereby enhancing patient access to innovative orthopedic implants.
  • Code Revision Impact: Effective January 1, 2026, the HCPCS code C1741's descriptor was updated to “absorbable metallic bone fixation anchor/screw,” explicitly focusing on absorbable metallic implants, aligning with FDA regulatory classifications and further solidifying Bioretec's market leadership.
  • Market Uniqueness: RemeOs™ is the only osteopromotive absorbable metal implant approved in the U.S., designed to support bone healing while gradually degrading and being replaced by native bone, thus reducing long-term risks and costs associated with permanent metallic implants, showcasing its innovative potential in orthopedics.
  • Regulatory Recognition: The TPT status aligns with the FDA's Breakthrough Device Designation and De Novo market authorization granted in March 2023, highlighting Bioretec's clinical and economic value in absorbable metal technology, further enhancing its competitiveness in the global market.
PRnewswire
1.0
2025-12-22PRnewswire
Bioretec Schedules 2026 Financial Reports and Annual General Meeting
  • Financial Reporting Schedule: Bioretec plans to publish its financial reports in 2025, with all reports available through company releases and on its website, ensuring timely access to key information for investors and enhancing transparency.
  • Annual General Meeting Date: The company has scheduled its Annual General Meeting for May 8, 2026, with the Board of Directors to provide further details later, aiming to strengthen communication and engagement with shareholders.
  • Innovative Product Line: Bioretec's RemeOs™ product line received market authorization in the U.S. in March 2023 and CE mark approval in Europe in January 2025, marking a technological breakthrough in biodegradable implants that is expected to drive future sales growth.
  • Global Market Presence: Bioretec's products are utilized in approximately 40 countries, showcasing its influence and market potential in the global orthopedic medical market, further solidifying its leadership position in the industry.
PRnewswire
7.5
2025-12-22PRnewswire
Bioretec Schedules 2026 Financial Reports and Annual General Meeting
  • Financial Reporting Schedule: Bioretec plans to publish multiple financial reports in 2025, with all reports being made available through company releases on its website, ensuring timely access to key information for investors.
  • Annual General Meeting Date: The company has scheduled its Annual General Meeting for May 8, 2026, with the Board of Directors to provide further details, reflecting the company's commitment to shareholder communication.
  • Innovative Product Line: Bioretec's RemeOs™ product line received market authorization in the U.S. in March 2023 and CE mark approval in Europe in January 2025, marking a technological breakthrough in biodegradable implants that is expected to drive future sales growth.
  • Global Market Presence: Bioretec's products are utilized in approximately 40 countries, demonstrating its extensive influence and market penetration in the global orthopedic medical market.
Globenewswire
7.5
2025-12-17Globenewswire
BRT Apartments Corp. Successfully Refinances $42.7 Million in Mortgages
  • Successful Refinancing: BRT Apartments Corp. has successfully refinanced three maturing mortgages totaling $42.7 million, with new mortgage debt amounting to approximately $71.9 million, resulting in an increase in the weighted average interest rate from 4.36% to 4.95%, thereby strengthening its financial foundation for future investments.
  • Enhanced Financial Flexibility: The refinancing allowed BRT to use $17.5 million of the proceeds to pay off the outstanding balance of its credit facility, enhancing the company's financial flexibility and positioning it to seize future investment opportunities in its core Sunbelt markets.
  • Long-Term Value Focus: CEO Jeffrey A. Gould emphasized that the company will continue to focus on value-enhancing opportunities aimed at driving substantial long-term shareholder value, reflecting confidence in the potential of future market opportunities.
  • Diversified Portfolio: As of December 17, 2025, BRT owns or has interests in 31 multi-family properties with 8,311 units, demonstrating its ongoing expansion in diversified investments and market coverage.
Yahoo Finance
8.5
2025-12-17Yahoo Finance
BRT Apartments Corp. Finalizes Debt Refinancing Deals
  • Refinancing Details: BRT Apartments Corp. has refinanced three maturing mortgages totaling $42.7 million, replacing them with new debt of approximately $71.9 million at a higher interest rate of 4.95% and a remaining term of about nine years.

  • Financial Strategy: The company utilized $17.5 million from the refinancing proceeds to pay off its credit facility, positioning itself to pursue future investment opportunities in core Sunbelt markets.

  • Company Overview: BRT is a real estate investment trust that owns and operates multi-family properties, currently holding interests in 31 properties with a total of 8,311 units across 11 states.

  • Leadership Statement: CEO Jeffrey A. Gould emphasized the company's focus on value-enhancing opportunities to drive long-term shareholder value following the successful refinancing.

PRnewswire
4.5
2025-12-16PRnewswire
Bioretec Updates Strategy for 2026-2028 with New Financial Targets
  • Strategic Overhaul: Bioretec's strategy for 2026-2028 focuses on commercial performance and sales acceleration in both the U.S. and international markets, aiming for growth through ongoing R&D and expansion of the RemeOs™ product family.
  • Innovation-Driven: The company is committed to establishing a competitive advantage through leading materials science and clinical evidence generation, with the goal of becoming a recognized player in the global orthopedic market, particularly in absorbable metal implants by the end of the strategy period.
  • Financial Targets: Despite planned strategic investments in R&D and commercialization, Bioretec does not expect to achieve cash flow positivity or profitability during this period, indicating a focus on long-term growth.
  • Pipeline Update: Bioretec plans to introduce a new product every 12-18 months, particularly expanding the RemeOs™ product family to meet market demand for high-performance absorbable implants, further solidifying its market position.
Wall Street analysts forecast BRT stock price to rise
1 Analyst Rating
Wall Street analysts forecast BRT stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
20.00
Averages
20.00
High
20.00
Current: 0.000
sliders
Low
20.00
Averages
20.00
High
20.00
Citizens JMP
Outperform
downgrade
$24 -> $20
AI Analysis
2025-11-18
Reason
Citizens JMP
Price Target
$24 -> $20
AI Analysis
2025-11-18
downgrade
Outperform
Reason
Citizens JMP lowered the firm's price target on BRT Apartments to $20 from $24 and keeps an Outperform rating on the shares following the Q3 print. The firm expects fundamentals to provide a favorable backdrop next year, and thinks additional capital could be accessed through debt refinancing in the future to unlock opportunities for value creation, the analyst tells investors in a research note.
B. Riley
Buy
maintain
$21
2025-10-01
Reason
B. Riley
Price Target
$21
2025-10-01
maintain
Buy
Reason
B. Riley raised the firm's price target on BRT Apartments to $21 from $19.50 and keeps a Buy rating on the shares. The firm sees the company benefitting from the lower interest rate environment. BRT offers \"compelling value\" at current share levels despite its small cap size and limited trading volume, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BRT
Unlock Now

Valuation Metrics

The current forward P/E ratio for BRT Apartments Corp (BRT.N) is -24.72, compared to its 5-year average forward P/E of -14.15. For a more detailed relative valuation and DCF analysis to assess BRT Apartments Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-14.15
Current PE
-24.72
Overvalued PE
34.08
Undervalued PE
-62.37

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
41.45
Current EV/EBITDA
17.79
Overvalued EV/EBITDA
86.01
Undervalued EV/EBITDA
-3.11

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
5.26
Current PS
2.93
Overvalued PS
8.16
Undervalued PS
2.36

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what is a stock to hold for 1 year
Intellectia · 62 candidates
Dividend Yield Ttm: >= 2Beta: ModerateRiskRevenue 5yr Cagr: >= 10Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
SFL logo
SFL
SFL Corporation Ltd
1.12B
GMRE logo
GMRE
Global Medical REIT Inc
482.80M
BRLT logo
BRLT
Brilliant Earth Group Inc
162.18M
IFF logo
IFF
International Flavors & Fragrances Inc
18.26B
BIPC logo
BIPC
Brookfield Infrastructure Corp
5.99B
BRT logo
BRT
BRT Apartments Corp
284.55M

Whales Holding BRT

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is BRT Apartments Corp (BRT) stock price today?

The current price of BRT is 14.3 USD — it has decreased -1.04

What is BRT Apartments Corp (BRT)'s business?

BRT Apartments Corp. is a real estate investment trust that owns, operates, and to a lesser extent, holds interest in joint ventures that own and operate multifamily properties. The Company owns or has interests in over 31 multifamily properties with 8,311units in 11 states and has preferred equity investments in two multi-family properties. Generally, its multifamily properties are garden apartments and, to a lesser extent, mid-rise or town home style properties that provide residents with amenities, such as a clubhouse, swimming pool, laundry facilities and Internet access. In addition to its multifamily properties and preferred loan investments, the Company owns assets, and in particular, real estate assets. Its properties include Silvana Oaks Apartments, Avondale Station, Brixworth at Bridge Street, Newbridge Commons, Crossings of Bellevue, Avalon Apartments, Parkway Grande, Woodland Trails, Grove at River Place, Kilburn Crossing, The Woodland Apartments, and others.

What is the price predicton of BRT Stock?

Wall Street analysts forecast BRT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRT is20.00 USD with a low forecast of 20.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is BRT Apartments Corp (BRT)'s revenue for the last quarter?

BRT Apartments Corp revenue for the last quarter amounts to 24.43M USD, increased 0.16

What is BRT Apartments Corp (BRT)'s earnings per share (EPS) for the last quarter?

BRT Apartments Corp. EPS for the last quarter amounts to -0.14 USD, increased 16.67

How many employees does BRT Apartments Corp (BRT). have?

BRT Apartments Corp (BRT) has 8 emplpoyees as of March 11 2026.

What is BRT Apartments Corp (BRT) market cap?

Today BRT has the market capitalization of 274.84M USD.